The hypothesis that self as well as foreign proteins are processed into peptides and presented by major histocompatibility complex antigens leads to a set of working principles that could govern cellular interactions in immune responses. In particular, "idiopeptides," derived from immunoglobulins and T-cell receptors and recognized by appropriate T cells, are expected to play an important regulatory role. We show here that these speculations fit into a consistent view of the immune system.
In the past few years, a remarkable series of experiments has cast light on the function of class I and class II molecules of the major histocompatibility complex (MHC). A growing body of evidence enforces the view that class II MHC molecules bind peptides derived from "processed" (i.e., partially degraded) antigen and expose them on the cell surface (1) (2) (3) . Importantly, recent experiments indicate that class I MHC molecules could do the same (4) (5) (6) . The primary function of MHC molecules might thus be to present peptides derived from processed proteins.
Assigning a molecular function to MHC molecules is a major accomplishment because they play a pivotal role in regulatory interactions between cells of the immune system. It is well established that the activation and action of various types of T lymphocytes (TH, helper; Ts, suppressor; CTL, cytolytic) requires recognition by T-cell receptors (TCR) of (processed) antigen in association with MHC molecules on the surface of antigen-presenting cells (APCs) or target cells.
Under the assumption that the actual function of MHC molecules relies on peptide presentation, we have proposed a logical generalization based on an interpretation of results by Townsend et al. (4, 5) -namely, that self, as well as foreign proteins, can yield peptides presented by MHC molecules (7, 8) . Cells expressing MHC molecules would thus be permanently coated with a set of distinct peptides somehow reflecting their protein content. For example, somatic cells, most of which express class I MHC molecules, would display myriads of self peptides associated to the latter. APCs (i.e., macrophages, dendritic cells, B cells), which express both class I and class II MHC molecules, would be loaded with antigen-derived peptides in addition to self peptides. Finally, B cells producing a given antibody would expose peptides derived from it, called antibody idiopeptides (designated Ab), while T cells expressing TCR could expose TCR idiopeptides (designated TCR). Therefore, the generalization proposed under our initial peptidic self model (7, 8) leads to two major predictions: (i) the presentation of self peptides by MHC molecules, and (it) the existence of idiopeptides, which, as discussed below, could constitute an important class of regulatory elements. Here, we delineate the implications arising from these premises and show that they lead to a consistent view of the immune system.
WORKING PRINCIPLES
Presentation by MHC Molecules. So far, little is known about the mechanisms of antigen presentation, but they are likely to be very complex. It appears that processing of proteins usually (but probably not exclusively) takes place intracellularly. However, endogenous and endocytosed proteins could be processed differently. The amounts of class I and class II MHC molecules vary in different cell types. Both can be internalized and recycled, albeit differentially in various cell types. Thus, activated B cells spontaneously recycle their class II molecules and activated T cells recycle their class I molecules (9, 10) . In the latter case, the endocytic pathway is similar to that followed by the transferrin receptor (10) . Furthermore, the intracellular route followed by newly synthesized class II molecules crosses that of the recycling transferrin receptor (11 offered the opportunity to cross-react with one of the thousands of distinct peptides present on the surface of the alloreactive target (8) . Possible Regulatory Roles of Idiopeptides. The predicted existence of idiopeptides playing a regulatory role in immune responses, although hypothetical, fits the conclusions of several reports. It seems that IgG2a allotypes require a presentation process to elicit a T-cell response (16) . X2 light (L)-chain idiotopes and chemically synthesized peptides have a similar effect in a syngeneic T-cell response (17) , and a MHC-linked gene control of helper T cells specific for variable-region heavy-chain (VH) determinants has been demonstrated (18) . On the other hand, one should question the existence of T cells responsive to idiopeptides. Synthetic peptides corresponding to VH hypervariable regions are highly immunogenic in a xenogenic host (19) . In a few instances, anti-idiotypic TH cells have been convincingly demonstrated (20, 21) . The immunoglobulin H-chain locus has been shown to influence the repertoire of CTLs (22) . More generally, anti-idiotypic T cells are implied by, and thereby implicitly postulated in, the network theory (23) . Certain anti-idiotypic T cells could thus respond to antibody idiopeptides rather than idiotopes as previously assumed (an idiotope possibly involving three-dimensional structures produced by nonconnex amino acid residues of the same or different chains of an antibody). In summary, the relevant evidence is scarce, but to our knowledge it is compatible with and does not rule out the existence of idiopeptides. Three conclusions would follow.
First, both chains ofantibodies and TCRs could yield specific idiopeptides. Their regulatory effects could be synergistic but also affect cells making other heterodimers sharing one of the chain or some ofthe idiopeptides. [For example, thejoint action of TH(VHAb) and TH(VLAb) could yield maximum stimulation of B(Ab) cells but TH(VHAb) could also stimulate B(Ab') cells where Ab' shares the same VH chain as Ab.] Recent data with transgenic mice carrying exogenous VH genes could be interpreted in this way (24) .
Second, regulatory phenomena involving idiopeptides should in general appear as MHC restricted. It should be noted, however, that some of the nonclassical class I MHC molecules (for example, those encoded in the mouse Qa-Tla complex), expressed on the surface of subsets of B cells and T cells, might serve to present idiopeptides. Since they are poorly polymorphic, MHC restriction could not be apparent in all situations. Other non-MHC-linked antigen-presenting molecules may be found in the future, and it may be recalled that exceptions to the rules of MHC restriction have been reported, including in T-cell/B-cell cooperation experiments (25) .
Finally, if idiopeptides do mediate regulations specific to the immune system, they must be foreign to the somatic self. Accordingly, we draw a distinction between the "somatic self' (i.e., the set of peptides derived from self nonimmunological molecules, as selected by the MHC molecules of the organism) and the "immunological self" (i.e., the set of MHC-presented peptides derived from immunological molecules during the lifetime of the organism) (7).
Rules for Cellular Recognition. TH cells are activated by contact with APCs presenting the processed antigen (i.e., peptides) in association with class II MHC molecules. CTL recognize (processed) antigen in association with class I MHC molecules on their targets, but sometimes with class II MHC molecules as well (12) . For Ts cells, class II restriction has been mostly reported (26) (27) (28) , but the involvement of class I molecules (as in CTL) remains possible.
In our interpretation of MHC restriction, TCRs per se (i.e., heterodimers of polymorphic chains) do not recognize the polymorphic parts of MHC molecules. If such is the case, they may also be blind to the presenting class I or class II MHC molecule (8) . As suggested by Goverman et al. (25) , the discrimination between class I-and class II-mediated presentation could be achieved by accessory molecules. It might also depend on the affinity ofTCRs for their specific antigens, which, when plentiful, could make accessory molecules dispensable (29) .
We mentioned above the possibility that internalized proteins are preferentially presented as peptides by actively recycling MHC molecules-that is, in general, class II in B cells, and class I in activated T cells (9, 10 (ii) A resting B cell, with some 105 antibody molecules of the appropriate specificity, binds the X protein, internalizes it, processes it as any other APC, and presents X peptides associated with class II (and, in some cases, class I) MHC molecules. As strongly supported by the experiments of Lanzavecchia (30) , the cooperation between TH(X) and B(Ab) cells involves not a protein bridge, but the peptide bridge illustrated in Fig. 1 .
This scheme accounts for an important feature of the antibody response-namely, the selection of antibodies with relatively high affinity for the X antigen, since B cells bearing antibody with a high affinity for X have a better chance to be activated.
(Mi) With time, the X antigen and TH(X) cells disappear. However, the antigen-driven antibody production may only be a component of the primary response (31, 32) . Upon massive production of antibody, some of it (particularly the IgM and IgG isotypes) could be processed and presented as Ab by APCs, or by the activated B cells themselves, which internalize it and display enhanced class II expression. This would trigger TH(Ab) and restimulate B(Ab) cells (which expose Ab) (Fig. 2) . Several reports show that the injection of a given antibody results in increased synthesis of antibodies with similar specificity and/or idiotypes (31, (33) (34) (35) (36) . These data have been taken in support of, or interpreted in the frame of, Jerne's network theory (23) (that is, in the usual terminology, reflecting Ab2-instructed antibody synthesis). In our interpretation, they could reveal a direct TH(Ab)-mediated induction of B(Ab) cells by the antibody. An idiopeptidic relay could thus lengthen the X antigen-driven phase of the primary response. (Anti-idiopeptidic relays could also be included, but they may lead to closed regulatory loops: see figure 3 in ref. Suppression by Ts and/or CTL cells could occur in different ways. In several systems, the determinants responsible for suppression and help have been found to be separate (37, 38 The Secondary Response. The success of the secondary response may require that the homeostatic loop described above is broken. TH(X) cells induced by reinjection of X may be unable to stimulate B(Ab) cells. They might, however, activate those B(Ab*) cells that produce a mutated antibody (Ab*) still able to bind X, but such that Ab* escapes suppression by Ts(Ab). This selective pressure may account for the wider and wider occurrence of somatic mutations in antibodies and the use of distinct germ-line V genes upon repeated immunization (45) . Somatic mutations would thus be largely irrelevant to an increase of affinity for antigen.
Response to Coupled Antigens. If peptide presentation by MHC molecules is as selective as we anticipate, it is no surprise that many peptides are poorly immunogenic except when polymerized or coupled to an immunogenic carrier. What happens upon immunization with a peptide (P) coupled to a carrier (X)? The P-X complex is taken up by APCs and processed into P and X. IfP can be presented by class II MHC molecules, a B(AbP) cell response should normally follow (AbP represents anti-P antibody); coupling to the carrier served to promote peptide presentation, perhaps by helping uptake by APCs. However, if P is not presented, a B(AbP) cell response should still be obtained. This is because B(AbP) cells bind P-X, process it, and expose X peptides, allowing activation by TH(X) cells, which are normally stimulated (Fig.  3A) .
This rationale explains how antibodies are made against nonimmunogenic peptides, including self molecules such as peptidic hormones. It also accounts for epitopic suppression, in which immunization by the X carrier weakens the anti-P response elicited by subsequent immunization with X-P. In this instance, the activated TH(X) cells, if limiting, will stimulate the numerous B(AbX) cells that are present, due to the first immunization, rather than the fewer B(AbP) cells that have never been activated and will thus be competed out (Fig. 3B ). This agrees with the sizes of the B(AbX) and B(AbP) cell compartments as recently measured (46) (Fig.  3B) . Allotype-specific suppression could be explained in a similar way (47) . Cellular Responses to Foreign Antigens. Most somatic cells express class I but not class II MHC molecules. In the peptidic self model (7), cells infected by a virus expose peptides derived from viral proteins in a class I context, amongst many selfpeptides derived from internal and surface proteins ofthe host cell. CTL reactions may thus be triggered by internal as well as external viral proteins (the former being, perhaps, favored by the intracellular routes leading to loading of peptides onto class I molecules).
Some of the minor transplantation antigens [as also suggested by Germain (13) logical and biochemical characterization (e.g., H-Y) has been so difficult.
Internal Activity of the Immune System. The frequency of mutations in complex organisms and their potential consequences are often overlooked. In mammals, considering only spontaneous point mutations (occurring at a rate of 10-), one or several point mutations must take place at each cellular division, yielding structural mutations in expressed proteins in one out ofevery hundred cells. Each cellular protein should, on the average, be mutated in 1 of 106 cells.
On this basis, we argued earlier that the somatic self may be placed under generalized immune surveillance (7, 8 (51, 52) and may thereby improve detection of alterations in the quality or amount of rare proteins.
In the schemes described above accounting for the stimulation of antibody synthesis, it is important that a distinction is made between the immunogenic peptide and the epitope of the native antigen recognized by the antibody. This explains tolerance-breaking experiments (reviewed and discussed in ref. 53 ) and leads to the concept that mutations producing altered self proteins may induce the synthesis of antibodies directed against self proteins themselves (Fig. 4) .
The immune system, even in the absence of any external stimulus, produces large amounts of so-called "natural" antibodies (54) , which often display auto-and multireactivity (i.e., they react against self proteins and several antigens) (55) . We propose that at least some of these natural antibodies are raised by mutated selfproteins. They could help in the clearance of proteins released by dead cells, which would favor their opsonization and restimulate their synthesis. The most abundant proteins would be more likely to induce an autoantibody response. Synthesis of polyreactive autoantibodies might be favored because their producing B cells might be polystimulated by several types of TH cells. Various cascades, including those produced by the presentation of idiopeptides, might lead with time to the establishment of a connective network, a feature displayed by natural antibodies, at least in the newborn animal (55) .
Ontogeny. The ontogeny of the immune system could then fit in a frame where the somatic self creates a "hole" in the developing T cells, while the immunological self and altered self generated by the uneluctable flow of mutations are driving forces in the expansion of the B-cell and T-cell repertoires. It is agreed that autoreactive T cells are depleted in the thymus, where self peptides are presumably presented in association with MHC molecules by a variety of cells. It should be noted that idiopeptides should not appear in the thymus and be seen as self because they are exposed on peripheral B and T cells (TCR being presented only by activated T cells). In this scheme, clonal deletion and/or inactivation of anti-self B cells is not compulsory, while, in fact, their existence is implied by the occurrence of natural antibodies.
The B-cell repertoire, however, could be internally activated by mutant self proteins and idiopeptides (as well as by foreign antigens). For example, it may be relevant that pre-B cells synthesize VH chains devoid of constant region (56) addition, our emphasis on peptide presentation does not preclude the possibility that denatured or native proteins that happen to expose the appropriate site are bound as such by MHC molecules. This would account for exceptions to the requirement for antigen processing and for examples of conformational-dependent recognition of certain antigens by T cells (58) . In spite of these multiple oversimplifications, the edifice built with the above working principles is internally consistent and compatible with most of the available evidence. It also displays some explicative and predictive value in areas of high theoretical and practical importance, such as tolerance, synthetic vaccines, and autoimmunity. In the latter case, it is conceivable that mutations could generate undue coincidences between the somatic self and the immunological self. In addition, altered regulations leading to the presentation of rare self proteins (and, thereby, never seen by the immune system) could trigger autoimmune reactions against the deregulated cells or tissue.
In our view, the somatic and the immunological self are under mutual intense co-selection, because certain overlaps are forbidden. Presentation by MHC molecule is also open to selection (for example, one could argue that albumin is so abundant that it would compete out most antigen presentation by circulating APCs, unless it evolved in such a way as not to be taken up, processed, or presented).
Finally, we predict "idiopeptidic" regulatory loops rather different from the usual version of the intricate self-centered idiotypic network (23) . The completeness and "openness" of the latter (59) could make it hardly "revealable." By involving idiopeptides rather than idiotopes, we picture the regulation of immune responses with a limited number of cellular interactions and simple regulatory loops, which need not be indefinitely extended in a recurrent fashion. Instead, the minimal loop (Fig. 2) displays the interesting property that antibodies induced by (Ab) mimic part of their antigenic stimulus (55) (providing a basis for a different understanding of "internal image").
As speculative as it stands, this extension of our initial "peptidic self" model leads to testable hypotheses. Not all may be true, but they may, hopefully, be useful in stimulating informative experiments.
